Global Microneedle Drug Delivery Systems Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01243186

Publication Date:

January 11, 2024

Pages:

116

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Microneedle Drug Delivery Systems market size was valued at US$ 3 million in 2023. With growing demand in downstream market, the Microneedle Drug Delivery Systems is forecast to a readjusted size of US$ 147.3 million by 2030 with a CAGR of 77.8% during review period.
The research report highlights the growth potential of the global Microneedle Drug Delivery Systems market. Microneedle Drug Delivery Systems are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Microneedle Drug Delivery Systems. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Microneedle Drug Delivery Systems market.
Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.
In this report, we mainly study the forecast market due to there is no product on the market, most product on the research.
Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.
The classification of Microneedle Drug Delivery Systems includes Hollow Microneedle Technology, Solid Microneedle Technology and Dissolving Microneedles Technology, and the proportion of Hollow Microneedle Technology occupies the most proportions.
Microneedle Drug Delivery Systems is widely used in Drug Delivery, Vaccine Delivery and other field. The most proportion of Microneedle Drug Delivery Systems is used for vaccine delivery.
3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Key Features:
The report on Microneedle Drug Delivery Systems market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Microneedle Drug Delivery Systems market. It may include historical data, market segmentation by Type (e.g., Hollow Microneedle Technology, Solid Microneedle Technology), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Microneedle Drug Delivery Systems market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Microneedle Drug Delivery Systems market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Microneedle Drug Delivery Systems industry. This include advancements in Microneedle Drug Delivery Systems technology, Microneedle Drug Delivery Systems new entrants, Microneedle Drug Delivery Systems new investment, and other innovations that are shaping the future of Microneedle Drug Delivery Systems.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Microneedle Drug Delivery Systems market. It includes factors influencing customer ' purchasing decisions, preferences for Microneedle Drug Delivery Systems product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Microneedle Drug Delivery Systems market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Microneedle Drug Delivery Systems market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Microneedle Drug Delivery Systems market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Microneedle Drug Delivery Systems industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Microneedle Drug Delivery Systems market.
Market Segmentation:
Microneedle Drug Delivery Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Hollow Microneedle Technology
Solid Microneedle Technology
Dissolving Microneedles Technology
Segmentation by application
Drug Delivery
Vaccine Delivery
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Microneedle Drug Delivery Systems Market Size 2019-2030
2.1.2 Microneedle Drug Delivery Systems Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Microneedle Drug Delivery Systems Segment by Type
2.2.1 Hollow Microneedle Technology
2.2.2 Solid Microneedle Technology
2.2.3 Dissolving Microneedles Technology
2.3 Microneedle Drug Delivery Systems Market Size by Type
2.3.1 Microneedle Drug Delivery Systems Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Microneedle Drug Delivery Systems Market Size Market Share by Type (2019-2024)
2.4 Microneedle Drug Delivery Systems Segment by Application
2.4.1 Drug Delivery
2.4.2 Vaccine Delivery
2.5 Microneedle Drug Delivery Systems Market Size by Application
2.5.1 Microneedle Drug Delivery Systems Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Microneedle Drug Delivery Systems Market Size Market Share by Application (2019-2024)
3 Microneedle Drug Delivery Systems Market Size by Player
3.1 Microneedle Drug Delivery Systems Market Size Market Share by Players
3.1.1 Global Microneedle Drug Delivery Systems Revenue by Players (2019-2024)
3.1.2 Global Microneedle Drug Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Microneedle Drug Delivery Systems Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Microneedle Drug Delivery Systems by Regions
4.1 Microneedle Drug Delivery Systems Market Size by Regions (2019-2024)
4.2 Americas Microneedle Drug Delivery Systems Market Size Growth (2019-2024)
4.3 APAC Microneedle Drug Delivery Systems Market Size Growth (2019-2024)
4.4 Europe Microneedle Drug Delivery Systems Market Size Growth (2019-2024)
4.5 Middle East & Africa Microneedle Drug Delivery Systems Market Size Growth (2019-2024)
5 Americas
5.1 Americas Microneedle Drug Delivery Systems Market Size by Country (2019-2024)
5.2 Americas Microneedle Drug Delivery Systems Market Size by Type (2019-2024)
5.3 Americas Microneedle Drug Delivery Systems Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microneedle Drug Delivery Systems Market Size by Region (2019-2024)
6.2 APAC Microneedle Drug Delivery Systems Market Size by Type (2019-2024)
6.3 APAC Microneedle Drug Delivery Systems Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Microneedle Drug Delivery Systems by Country (2019-2024)
7.2 Europe Microneedle Drug Delivery Systems Market Size by Type (2019-2024)
7.3 Europe Microneedle Drug Delivery Systems Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Microneedle Drug Delivery Systems by Region (2019-2024)
8.2 Middle East & Africa Microneedle Drug Delivery Systems Market Size by Type (2019-2024)
8.3 Middle East & Africa Microneedle Drug Delivery Systems Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Microneedle Drug Delivery Systems Market Forecast
10.1 Global Microneedle Drug Delivery Systems Forecast by Regions (2025-2030)
10.1.1 Global Microneedle Drug Delivery Systems Forecast by Regions (2025-2030)
10.1.2 Americas Microneedle Drug Delivery Systems Forecast
10.1.3 APAC Microneedle Drug Delivery Systems Forecast
10.1.4 Europe Microneedle Drug Delivery Systems Forecast
10.1.5 Middle East & Africa Microneedle Drug Delivery Systems Forecast
10.2 Americas Microneedle Drug Delivery Systems Forecast by Country (2025-2030)
10.2.1 United States Microneedle Drug Delivery Systems Market Forecast
10.2.2 Canada Microneedle Drug Delivery Systems Market Forecast
10.2.3 Mexico Microneedle Drug Delivery Systems Market Forecast
10.2.4 Brazil Microneedle Drug Delivery Systems Market Forecast
10.3 APAC Microneedle Drug Delivery Systems Forecast by Region (2025-2030)
10.3.1 China Microneedle Drug Delivery Systems Market Forecast
10.3.2 Japan Microneedle Drug Delivery Systems Market Forecast
10.3.3 Korea Microneedle Drug Delivery Systems Market Forecast
10.3.4 Southeast Asia Microneedle Drug Delivery Systems Market Forecast
10.3.5 India Microneedle Drug Delivery Systems Market Forecast
10.3.6 Australia Microneedle Drug Delivery Systems Market Forecast
10.4 Europe Microneedle Drug Delivery Systems Forecast by Country (2025-2030)
10.4.1 Germany Microneedle Drug Delivery Systems Market Forecast
10.4.2 France Microneedle Drug Delivery Systems Market Forecast
10.4.3 UK Microneedle Drug Delivery Systems Market Forecast
10.4.4 Italy Microneedle Drug Delivery Systems Market Forecast
10.4.5 Russia Microneedle Drug Delivery Systems Market Forecast
10.5 Middle East & Africa Microneedle Drug Delivery Systems Forecast by Region (2025-2030)
10.5.1 Egypt Microneedle Drug Delivery Systems Market Forecast
10.5.2 South Africa Microneedle Drug Delivery Systems Market Forecast
10.5.3 Israel Microneedle Drug Delivery Systems Market Forecast
10.5.4 Turkey Microneedle Drug Delivery Systems Market Forecast
10.5.5 GCC Countries Microneedle Drug Delivery Systems Market Forecast
10.6 Global Microneedle Drug Delivery Systems Forecast by Type (2025-2030)
10.7 Global Microneedle Drug Delivery Systems Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 KINDEVA
11.1.1 KINDEVA Company Information
11.1.2 KINDEVA Microneedle Drug Delivery Systems Product Offered
11.1.3 KINDEVA Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 KINDEVA Main Business Overview
11.1.5 KINDEVA Latest Developments
11.2 Zosano Pharma
11.2.1 Zosano Pharma Company Information
11.2.2 Zosano Pharma Microneedle Drug Delivery Systems Product Offered
11.2.3 Zosano Pharma Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Zosano Pharma Main Business Overview
11.2.5 Zosano Pharma Latest Developments
11.3 Becton-Dickinson(BD)Technologies
11.3.1 Becton-Dickinson(BD)Technologies Company Information
11.3.2 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Product Offered
11.3.3 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Becton-Dickinson(BD)Technologies Main Business Overview
11.3.5 Becton-Dickinson(BD)Technologies Latest Developments
11.4 Nanopass Technologies
11.4.1 Nanopass Technologies Company Information
11.4.2 Nanopass Technologies Microneedle Drug Delivery Systems Product Offered
11.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Nanopass Technologies Main Business Overview
11.4.5 Nanopass Technologies Latest Developments
11.5 Corium
11.5.1 Corium Company Information
11.5.2 Corium Microneedle Drug Delivery Systems Product Offered
11.5.3 Corium Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Corium Main Business Overview
11.5.5 Corium Latest Developments
11.6 Valeritas
11.6.1 Valeritas Company Information
11.6.2 Valeritas Microneedle Drug Delivery Systems Product Offered
11.6.3 Valeritas Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Valeritas Main Business Overview
11.6.5 Valeritas Latest Developments
11.7 Nitto
11.7.1 Nitto Company Information
11.7.2 Nitto Microneedle Drug Delivery Systems Product Offered
11.7.3 Nitto Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Nitto Main Business Overview
11.7.5 Nitto Latest Developments
11.8 Microdermics
11.8.1 Microdermics Company Information
11.8.2 Microdermics Microneedle Drug Delivery Systems Product Offered
11.8.3 Microdermics Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Microdermics Main Business Overview
11.8.5 Microdermics Latest Developments
11.9 TheraJect, Inc
11.9.1 TheraJect, Inc Company Information
11.9.2 TheraJect, Inc Microneedle Drug Delivery Systems Product Offered
11.9.3 TheraJect, Inc Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 TheraJect, Inc Main Business Overview
11.9.5 TheraJect, Inc Latest Developments
11.10 Vaxxas
11.10.1 Vaxxas Company Information
11.10.2 Vaxxas Microneedle Drug Delivery Systems Product Offered
11.10.3 Vaxxas Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Vaxxas Main Business Overview
11.10.5 Vaxxas Latest Developments
11.11 Lohmann Therapie-Systeme AG
11.11.1 Lohmann Therapie-Systeme AG Company Information
11.11.2 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Product Offered
11.11.3 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Lohmann Therapie-Systeme AG Main Business Overview
11.11.5 Lohmann Therapie-Systeme AG Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂